Saturday 17 October 2026 Export ADAG’s income statement to Excel — free account

Adagene Inc. Sponsored ADR

ADAG Healthcare Biotechnology

Adagene Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $7.7 million, up 7,333.0% from fiscal 2024. Insiders bought in the last twelve months.

2.06 0.34 −14.17%

Follow ADAG

Alert me

Market cap: $161.1M
P/E: 0.0×
Fwd P/E: −2.2×
Dividend yield: —
F-score: 4/9
Altman Z: −4.64
Beneish M: 61.98
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '24	Jun '25	Dec '25	Jun '26
ROE Full definition →	+8 more TTM periods Free account	0.00%	0.00%	0.00%	0.00%
ROA Full definition →		0.00%	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow Full definition →		(120.95)	(82.78)	(69.93)	(71.41)
Capital Expenditures Full definition →		(0.81)	(0.13)	(0.06)	(0.20)
Other line items
Cash ROIC Full definition →		(81.14%)	(78.63%)	(62.59%)	(32.65%)
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		0.00	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		0.39	2.59	0.21	2.19
Capex/Depreciation Full definition →		(0.25)	(0.05)	(0.04)	(0.13)
Operating CF per Share Full definition →		0.00	0.00	0.00	0.00
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates